Skip to content
★ Sign in to follow
AF

Alison Frances Lawton

X4 Pharmaceuticals, IncCubist Pharmaceuticals IncVerastem, Inc.
Total declarations
9
Companies
3
▲ Purchases (1 ops.)
€18k
▼ Sales (0 ops.)
—

Latest filing published 11 Jun 2024 for X4 Pharmaceuticals, Inc.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 12 Nov 2014 · 4379 days ago · €18k
    -78.1%
    Entry US$108.72 · Close at T+365 US$23.76

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Alison Frances Lawton: trading record in brief

Alison Frances Lawton discloses dealings in 3 companies, chiefly Cubist Pharmaceuticals Inc, X4 Pharmaceuticals, Inc and Verastem, Inc. In total, 9 filings cover trades dated from 6 June 2013 to 10 June 2024.

Every open-market trade on record is a purchase: 1 purchase worth €18k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants and 2 option exercises.

The record was last updated on 11 June 2024 with a share grant in X4 Pharmaceuticals, Inc. The last purchase on record was published on 12 November 2014, which is 4,379 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Alison Frances Lawton

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations